Podcast Episode 11: Maeve Magner on the Unique Supply Chain Complexities of Emerging Markets
- Despite a high burden of disease, limited supply, and a complex financial model, emerging markets are often early adopters of supply chain technology.
- Lessons learned from Ebola have provided a framework for COVID-19 response in African markets, including restricting travel and contact-tracing capabilities, but challenges persist.
- Emerging markets are making progress toward patient-centric models, but in many cases have different drivers than in industrialized markets.
July 19, 2020
Global health expert Maeve Magner joins TraceLink’s Roddy Martin on The Patient Driven Supply Network to discuss how large-scale disruptions like COVID-19 can create complex challenges—and opportunities—for emerging markets across the world.
Return to: The Patient-Driven Supply Network